SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-10-047120
Filing Date
2010-08-27
Accepted
2010-08-27 16:09:47
Documents
3
Effectiveness Date
2010-08-27

Document Format Files

Seq Description Document Type Size
1 v195157_defr14a.htm DEFR14A 254265
2 GRAPHIC proxy1.jpg GRAPHIC 385415
3 GRAPHIC proxy2.jpg GRAPHIC 217514
  Complete submission text file 0001144204-10-047120.txt   1086684
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEFR14A | Act: 34 | File No.: 000-25169 | Film No.: 101044194
SIC: 2834 Pharmaceutical Preparations